News

After 14 reported cases, Health Canada is warning that glatiramer acetate products for MS can cause anaphylaxis, a severe allergic reaction.
A study identified a protein that stalls myelin repair in the brain, suggesting that targeting it could be a strategy for MS treatment.
Columnist Leigh Anne Nelson describes the odd itching sensation she experiences due to MS, which occurs randomly and suddenly.
The UAE became the first country to approve tolebrutinib, making it available to adults with nonrelapsing secondary progressive MS.
Columnist Ben Hofmeister knows what it's like to grieve his multiple sclerosis and has learned what well-meaning words not to say.
A new artificial intelligence model suggests that MS should be classified along a single disease continuum rather than into ...
Civicascript said its low-cost generic version of Ampyra is now available in the U.S., offering significant savings and ...
The International Progressive MS Alliance has unveiled a new database to speed up the development of treatments for ...
Columnist Ben Hofmeister doesn't like presenting the unedited version of himself to the world — even if, at times, he should.
A ketogenic diet may help improve neurological function and fatigue in MS patients, but more research is needed, an analysis found.